文献速递妇科生殖医学

澳大利亚临床医生对多囊卵巢综合征诊断的看法:一项定性研究

Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究通过电话半结构化访谈,于2017年9月至2018年7月招募36名澳大利亚临床医生(全科医生15名、妇科医生10名、内分泌科医生11名),探讨其对多囊卵巢综合征(PCOS)诊断的看法及处理复杂性和不确定性的方式。结果显示,临床医生在诊断标准、证据局限性和误解等方面面临诸多不确定性,并对诊断不足和过度诊断的风险表示担忧。

要点

  • PCOS诊断存在诊断切点不统一、误诊风险等不确定性。
  • 临床医生应首先将PCOS视为排除性诊断,谨慎下诊断。
  • 加强教育与沟通,减少诊断标签的潜在危害,提升以患者为中心的结局。

核心结论

  • 临床医生在PCOS诊断中需应对诊断标准、证据局限和误解等多方面复杂性与不确定性,并对诊断不足和过度诊断的风险表示担忧。

研究设计与样本

  • 定性研究,采用半结构化电话访谈,于2017年9月至2018年7月对36名澳大利亚临床医生(15名全科医生、10名妇科医生、11名内分泌科医生)进行访谈,采用框架分析法进行主题分析。

主要发现

  • 临床医生表达的不确定性和复杂性可归纳为三个领域:建立诊断、影响诊断过程的因素、处理挑战与不确定性的策略。
  • 临床医生对诊断不足和过度诊断的担忧程度不一;多数认为只要诊断正确并花时间评估患者期望、消除误解(尤其关于生育),诊断对女性有益。

临床怎么用

  • 临床医生建议首先将PCOS视为排除性诊断,在给出诊断前保持谨慎以减少误诊。
  • 在诊断标准更统一之前,与女性进行更透明的沟通有助于其理解诊断标准的不确定性和证据局限性。
  • 强调教育和 reassurance 的重要性,以尽量减少诊断的潜在有害影响并改善以患者为中心的结局。

局限性

  • 可能存在选择偏倚,对PCOS更了解的临床医生可能更倾向于参与。
  • 临床医生的观点在其他国家可能有所不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are clinicians' views about the diagnosis of polycystic ovary syndrome (PCOS), and how do they handle any complexities and uncertainties in practice? SUMMARY ANSWER: Clinicians have to navigate many areas of complexity and uncertainty regarding the diagnosis of PCOS, related to the diagnostic criteria, limitations in current evidence and misconceptions surrounding diagnosis, and expressed concern about the risk and consequences of both under- and overdiagnosis. WHAT IS KNOWN ALREADY: PCOS is a complex, heterogeneous condition with many areas of uncertainty, raising concerns about both underdiagnosis and overdiagnosis. Quantitative studies with clinicians have found considerable variation in diagnostic criteria used and care provided, as well as a lack of awareness around the breadth of PCOS features and poor uptake of recommended screening for metabolic complications. Clinicians' views about the uncertainties and complexities of diagnosing PCOS have not been explored. STUDY DESIGN, SIZE, DURATION: Semi-structured telephone interviews were conducted with clinicians from September 2017 to July 2018 to explore their perceptions about the diagnosis of PCOS, including how they handle any complexities and uncertainties in practice. PARTICIPANTS/MATERIALS, SETTING, METHODS: A group of 36 clinicians (15 general practitioners, 10 gynaecologists and 11 endocrinologists) currently practicing in Australia, were recruited through advertising via professional organisations, contacting a random sample of endocrine and gynaecology teams across Australia and snowballing. Transcribed audio-recordings were analysed thematically using Framework analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Clinicians expressed a range of uncertainties and complexities regarding the diagnosis of PCOS, which were organised into three areas: (i) establishing diagnosis (e.g. lack of standardisation regarding diagnostic cut-offs, risk of misdiagnosis), (ii) factors influencing the diagnostic process (e.g. awareness of limitations in evidence and consideration of the benefits and harms) and (iii) strategies for handling challenges and uncertainties (e.g. using caution and communication of uncertainties). Clinicians also varied in their concerns regarding under- and overdiagnosis. Overall, most felt the diagnosis was beneficial for women provided that it was the correct diagnosis and time was taken to assess patient expectations and dispel misconceptions, particularly concerning fertility. LIMITATIONS, REASONS FOR CAUTION: There is possible selection bias, as clinicians who are more knowledgeable about PCOS may have been more likely to participate. Clinicians' views may also differ in other countries. WIDER IMPLICATIONS OF THE FINDINGS: These findings underscore the vital need to first consider PCOS a diagnosis of exclusion and use caution before giving a diagnosis in order to reduce misdiagnosis, as suggested by clinicians in our study. Until there is greater standardisation of diagnostic criteria, more transparent conversations with women may help them understand the uncertainties surrounding the criteria and limitations in the evidence. Additionally, clinicians emphasised the importance of education and reassurance to minimise the potential harmful impact of the diagnosis and improve patient-centred outcomes. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the University of Sydney Lifespan Research Network and an NHMRC Program Grant (APP1113532). T.C. is supported by an Australian Government Research Training Program (RTP) Scholarship and a Sydney Medical School Foundation Scholarship, from the The University of Sydney, Australia. B.W.M. reports consultancy for ObsEva, Merck, Merck KGaA and Guerbet. No further competing interests exist. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Copp T, Muscat DM, Hersch J, et al. Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study. Hum Reprod. 2020. PMID: 32101283. doi:10.1093/humrep/deaa005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。